These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8549296)

  • 1. Analysis of quinolone resistance genes in a clinical isolate of quinolone-resistant MRSA.
    Kojima T; Yamagishi J; Oyamada Y; Yoshida H; Hattori H; Inoue M; Nakamura S
    Drugs; 1995; 49 Suppl 2():182-4. PubMed ID: 8549296
    [No Abstract]   [Full Text] [Related]  

  • 2. Occurrence of quinolone resistance in Staphylococcus aureus from nosocomial infection.
    Witte W; Grimm H
    Epidemiol Infect; 1992 Dec; 109(3):413-21. PubMed ID: 1468526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital.
    Shalit I; Berger SA; Gorea A; Frimerman H
    Antimicrob Agents Chemother; 1989 Apr; 33(4):593-4. PubMed ID: 2729953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unrelatedness of multiply resistant Staphylococcus aureus with resistance to methicillin and to quinolones (QR-MRSA) as evident from SmaI-digestion patterns of genomic DNA.
    Witte W; Cuny C; Claus H
    Zentralbl Bakteriol; 1993 Jun; 278(4):510-7. PubMed ID: 8102563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of 4-quinolone resistance in quinolone-resistant and methicillin-resistant Staphylococcus aureus isolates from Japan and China.
    Tanaka M; Zhang YX; Ishida H; Akasaka T; Sato K; Hayakawa I
    J Med Microbiol; 1995 Mar; 42(3):214-9. PubMed ID: 7884804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of BMS-284756, a novel des-fluoro(6) quinolone, against Staphylococcus aureus, including contributions of mutations to quinolone resistance.
    Low DE; Muller M; Duncan CL; Willey BM; de Azavedo JC; McGeer A; Kreiswirth BN; Pong-Porter S; Bast DJ
    Antimicrob Agents Chemother; 2002 Apr; 46(4):1119-21. PubMed ID: 11897603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of grlA mutations in clinical isolates of Staphylococcus aureus with different levels of quinolone resistance.
    Martínez JA; Ortiz G; Segovia M; Alonso MA; Gutiérrez MN; Muñoz JL; García-Rodríguez JA
    Antimicrob Agents Chemother; 1998 May; 42(5):1306-7. PubMed ID: 9593177
    [No Abstract]   [Full Text] [Related]  

  • 8. Quinolone susceptibility of norA-disrupted Staphylococcus aureus.
    Yamada H; Kurose-Hamada S; Fukuda Y; Mitsuyama J; Takahata M; Minami S; Watanabe Y; Narita H
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2308-9. PubMed ID: 9333072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of quinolone resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in Ontario, Canada.
    Harnett N; Brown S; Krishnan C
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1911-3. PubMed ID: 1952866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinolone resistance in Staphylococci: activities of new nonfluorinated quinolones against molecular targets in whole cells and clinical isolates.
    Roychoudhury S; Catrenich CE; McIntosh EJ; McKeever HD; Makin KM; Koenigs PM; Ledoussal B
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1115-20. PubMed ID: 11257024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of 3H-norfloxacin in methicillin-resistant Staphylococcus aureus.
    Cundy KV; Fasching CE; Willard KE; Peterson LR
    J Antimicrob Chemother; 1991 Oct; 28(4):491-7. PubMed ID: 1761443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of twenty-one antimicrobial agents including l-ofloxacin against quinolone-sensitive and -resistant, and methicillin-sensitive and -resistant Staphylococcus aureus.
    Peterson LR; Cooper I; Willard KE; Fasching CE; Sinn LM; Shanholtzer CJ; Gerding DN
    Chemotherapy; 1994; 40(1):21-5. PubMed ID: 8306811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on methicillin-resistant Staphylococcus aureus in China.
    Wang F; Wei MQ; Liu YK; Dai ZY
    Chin Med J (Engl); 1991 Jul; 104(7):585-90. PubMed ID: 1879222
    [No Abstract]   [Full Text] [Related]  

  • 14. Antimicrobial use and methicillin-resistant Staphylococcus aureus in a large nursing home.
    Drinka PJ; Gauerke C; Le D
    J Am Med Dir Assoc; 2004; 5(4):256-8. PubMed ID: 15228636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermutable and fluoroquinolone-resistant clinical isolates of Staphylococcus aureus.
    Trong HN; Prunier AL; Leclercq R
    Antimicrob Agents Chemother; 2005 May; 49(5):2098-101. PubMed ID: 15855537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimum inhibitory concentration (MIC) analysis and susceptibility testing of MRSA.
    Bou G
    Methods Mol Biol; 2007; 391():29-49. PubMed ID: 18025667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methicillin-resistant Staphylococcus aureus--a reappraisal.
    Keane CT; Coleman DC; Cafferkey MT
    J Hosp Infect; 1991 Nov; 19(3):147-52. PubMed ID: 1685502
    [No Abstract]   [Full Text] [Related]  

  • 18. Susceptibilities of healthcare- and community-associated methicillin-resistant staphylococci to the novel des-F(6)-quinolone DX-619.
    Watanabe S; Ito T; Hiramatsu K
    J Antimicrob Chemother; 2007 Dec; 60(6):1384-7. PubMed ID: 17890283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relapse of Staphylococcus aureus septicemia due to the emergence ofa fluoroquinolone-resistant mutant].
    Chomarat M; Vital-Durand D; Gerbaud G
    Presse Med; 1990 Feb; 19(6):265. PubMed ID: 2138301
    [No Abstract]   [Full Text] [Related]  

  • 20. Staphylococcal cassette chromosome mec and Panton-Valentine leukocidin characterization of methicillin-resistant Staphylococcus aureus clones.
    Moroney SM; Heller LC; Arbuckle J; Talavera M; Widen RH
    J Clin Microbiol; 2007 Mar; 45(3):1019-21. PubMed ID: 17192420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.